Paget's disease and bisphosphonate-associated osteonecrosis of the jaws.
Gueiros
Luiz Alcino
LA
Lopes
Márcio Ajudarte
MA
Leão
Jair Carneiro
JC
D000369:Aged, 80 and over; D050071:Bone Density Conservation Agents / Q000009:adverse effects*; D004164:Diphosphonates / Q000008:administration & dosage / Q000009:adverse effects*; D006801:Humans; D007093:Imidazoles / Q000008:administration & dosage / Q000009:adverse effects; D007275:Injections, Intravenous; D008297:Male; D008439:Maxillary Diseases / Q000139:chemically induced* / Q000188:drug therapy*; D010001:Osteitis Deformans / Q000188:drug therapy*; D010020:Osteonecrosis / Q000139:chemically induced*; D000077268:Pamidronate; D000077211:Zoledronic Acid
D050071:Bone Density Conservation Agents; D004164:Diphosphonates; D007093:Imidazoles; D000077211:Zoledronic Acid; D000077268:Pamidronate